ÂÜÀòÂÒÂ×

Andy Hudak is Vice President, R&D & Program Management at Cue Health, a health technology company whose mission is to enable personalized, proactive, and informed healthcare that empowers people to live their healthiest lives.

At Cue, Andy spearheaded the development of Cue’s mobile application software and system integration. Andy also helped lead the development and commercialization of Cue’s COVID-19 Test, which received a EUA from the FDA in June 2020 and the first-ever authorization of a molecular diagnostic test for non-prescription home use in March 2021.

In addition, Andy serves as program lead for Cue’s $481 million agreement with the U.S. Department of Defense to scale up Cue’s manufacturing and distribute 6 million COVID-19 tests, among other things. He also leads Cue’s $30 million contract with the HHS’s Biomedical Advanced Research and Development Authority (BARDA) to accelerate the development of the Cue Health Monitoring System, including influenza and COVID tests.

Andy holds Bachelor's and Master of Science degrees in biology from California State University, Long Beach.